Wilma van de Berg is senior neuroscientist, principal investigator, associate professsor at dept. Anatomy and Neurosciences, head of the research section Clinical Neuroanatomy and Biobanking (CNAB). She is founder and director of the Normal Aging Brain Collection (www.nabca.eu), which collects advanced postmortem MRI and high-quality brain tissue of non-demented elderly for stimulating translational research in neurosciences. Wilma van de Berg is an expert in human neuroanatomy, neuropathology and morphometry of Parkinson's disease. She has a strong interest in translating knowledge on pathogenesis in Parkinson's diseasse in novel (progression) biomarkers and developing new disease-modifying treatment strategies aiming to slow down or halt Parkinson’s disease progression. Her research team studies human brain morphology, neuropathological lesions and molecular mechanisms underlying alpha-synuclein aggregation in postmortem brain tissue of aged individuals and patients with Parkinson’s disease, Dementia with Lewy bodies and Alzheimer’s disease from macro-to-nanoscale using advanced MRI, correlative microscopic imaging and multi-omics methods. Wilma van de Berg has experience in conducting clinical studies (e.g. PROGRES-PD) in which Parkinson patients were followed for eight years to study relationship between biofluid markers and cognitive decline in PD. In close collaboration with acadmic and industry partners, she setup a large multicenter longitudinal observational study ‘Profiling Parkinson’s disease’ (ProPARK) to identify molecular profiles underlying disease severity, progression and adverse drug reactions and translate this knowledge into biomarker panels for next clinical trials.